Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cytokine Profile in Patients with Progressive Multiple Sclerosis and Its Association with Disease Progression and Disability.
Mental Health and Health-Related Quality of Life in Multiple Sclerosis Caregivers in Mexico.
Human myelin proteome and comparative analysis with mouse myelin.
High immunogenicity of intracellular myelin oligodendrocyte glycoprotein epitopes.
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.
Role of Pulmonary Evaluation in Diagnosis of Neurosarcoidosis.
Simultaneous early-onset immune thrombocytopenia and autoimmune thyroid disease following alemtuzumab treatment in relapsing-remitting multiple sclerosis.
Gender, ethnicity, and physician-patient communication about depression and anxiety in primary care.
A blood based 12-miRNA signature of Alzheimer disease patients.
Inflammation-independent defective early B cell tolerance checkpoints in rheumatoid arthritis.
GENETIC POLYMORPHISMS OF HUMAN β-DEFENSINS IN PATIENTS WITH MULTIPLE SCLEROSIS.
Emerging Role of P2X7 Receptors in CNS Health and Disease.
Key players in neurodegenerative disorders in focus - new insights into the proteomic profile of Alzheimer`s disease, schizophrenia, ALS and multiple sclerosis - 24th HUPO BPP Workshop: 29 September 2015, Vancouver, Canada.
B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation.
CellCept Drug Details
Cutaneous Adverse Events in the Randomized, Double-Blind, Active-Comparator DECIDE Study of Daclizumab High-Yield Process Versus Intramuscular Interferon Beta-1a in Relapsing-Remitting Multiple Sclerosis.
Levodopa-responsive Holmes' Tremor Caused by a Single Inflammatory Demyelinating Lesion.
The Indirect Costs of Multiple Sclerosis Associated With Absenteeism In Poland In 2013.
A Cost-Effectiveness Analysis of Fingolimod Versus Dimethyl Fumarate As A Second-Line Disease Modifying Treatment In Patients With Highly Active Relapsing-Remitting Multiple Sclerosis.
MicroRNA223 Promotes Pathogenic T Cell Development and Autoimmune Inflammation in Central Nerve System in Mice.
Nurse led telephone assessment of expanded disability status scale assessment in MS patients at high levels of disability.
Natalizumab continuation during pregnancy in a patient with previous severe IRIS syndrome.
MAG, myelin and overcoming growth inhibition in the CNS.
Kainic Acid-Induced Excitotoxicity Experimental Model: Protective Merits of Natural Products and Plant Extracts.
Disability may influence patient willingness to participate in decision making on first-line therapy in multiple sclerosis.
Pages
« first
‹ previous
…
723
724
725
726
727
728
729
730
731
…
next ›
last »